@article{17231,
  author = {Li Qiang and Grobbee D. and Ninomiya T. and de Galan Bastiaan and Kengne Andre and Woodward Mark and Zoungas Sophia and Marre M. and Heller S. and Chalmers J. and Billot Laurent and Neal Bruce and Patel Anushka and Macmahon S},
  title = {Severe hypoglycemia and risks of vascular events and death},
  abstract = {<p>
BACKGROUND: Severe hypoglycemia may increase the risk of a poor outcome in patients with type 2 diabetes assigned to an intensive glucose-lowering intervention. We analyzed data from a large study of intensive glucose lowering to explore the relationship between severe hypoglycemia and adverse clinical outcomes. METHODS: We examined the associations between severe hypoglycemia and the risks of macrovascular or microvascular events and death among 11,140 patients with type 2 diabetes, using Cox proportional-hazards models with adjustment for covariates measured at baseline and after randomization. RESULTS: During a median follow-up period of 5 years, 231 patients (2.1%) had at least one severe hypoglycemic episode; 150 had been assigned to intensive glucose control (2.7% of the 5571 patients in that group), and 81 had been assigned to standard glucose control (1.5% of the 5569 patients in that group). The median times from the onset of severe hypoglycemia to the first major macrovascular event, the first major microvascular event, and death were 1.56 years (interquartile range, 0.84 to 2.41), 0.99 years (interquartile range, 0.40 to 2.17), and 1.05 years (interquartile range, 0.34 to 2.41), respectively. During follow-up, severe hypoglycemia was associated with a significant increase in the adjusted risks of major macrovascular events (hazard ratio, 2.88; 95% confidence interval [CI], 2.01 to 4.12), major microvascular events (hazard ratio, 1.81; 95% CI, 1.19 to 2.74), death from a cardiovascular cause (hazard ratio, 2.68; 95% CI, 1.72 to 4.19), and death from any cause (hazard ratio, 2.69; 95% CI, 1.97 to 3.67) (P&lt;0.001 for all comparisons). Similar associations were apparent for a range of nonvascular outcomes, including respiratory, digestive, and skin conditions (P&lt;0.01 for all comparisons). No relationship was found between repeated episodes of severe hypoglycemia and vascular outcomes or death. CONCLUSIONS: Severe hypoglycemia was strongly associated with increased risks of a range of adverse clinical outcomes. It is possible that severe hypoglycemia contributes to adverse outcomes, but these analyses indicate that hypoglycemia is just as likely to be a marker of vulnerability to such events. (Funded by Servier and the National Health and Medical Research Council of Australia; ClinicalTrials.gov number, NCT00145925.).
</p>
},
  year = {2010},
  journal = {New England Journal of Medicine},
  volume = {363},
  edition = {2010/10/12},
  number = {15},
  pages = {1410-8},
  isbn = {1533-4406 (Electronic)0028-4793 (Linking)},
  note = {Zoungas, SophiaPatel, AnushkaChalmers, Johnde Galan, Bastiaan ELi, QiangBillot, LaurentWoodward, MarkNinomiya, ToshiharuNeal, BruceMacMahon, StephenGrobbee, Diederick EKengne, Andre PascalMarre, MichelHeller, SimonADVANCE Collaborative GroupRandomized Controlled TrialResearch Support, Non-U.S. Gov'tUnited StatesThe New England journal of medicineN Engl J Med. 2010 Oct 7;363(15):1410-8.},
  language = {eng},
}